Showing results (541-550 of 2,484) with videos related to
Sort By:
Pageof 249
Expert Review of Vaccines|April 26, 2024
The zebrafish as a potential model for vaccine and adjuvant developmentPeter J Hotez, Maria Elena Bottazzi, Nelufa Yesmin Islam, et al.Expert Review of Vaccines|February 3, 2026
Cost-effectiveness of a single dose of the adjuvanted RSVPreF3 vaccine for the prevention of respiratory syncytial virus (RSV) among patients with chronic obstructive pulmonary disease in ItalyAnna Puggina, Filippo Rumi, Eleftherios Zarkadoulas, et al.Expert Review of Vaccines|November 27, 2025
Incidence of stroke following COVID-19 vaccination: a nationwide self‑controlled risk interval study in QatarHiam Chemaitelly, Naveed Akhtar, Salman Al Jerdi, et al.Expert Review of Vaccines|November 17, 2025
Unravelling parental decision-making for adolescent HPV vaccination in China by COM-B framework: a discrete choice experimentNaiyang Shi, Shixin Xiu, Jiayu Wang, et al.Expert Review of Vaccines|November 29, 2025
Contextual adaptation and validation of the international Pro-VC-Be tool for measuring healthcare worker vaccine confidence in NigeriaJulius Salako, Damola Bakare, Kofoworola O Akinsola, et al.Expert Review of Vaccines|December 7, 2024
Modeling the potential public health and economic impact of different COVID-19 vaccination strategies with an adapted vaccine in the Kingdom of Saudi ArabiaNadine Al Akoury, Julia Spinardi, Hammam Haridy, et al.Expert Review of Vaccines|December 8, 2023
Unpacking adverse events and associations post COVID-19 vaccination: a deep dive into vaccine adverse event reporting system dataYiming Li, Sori K Lundin, Jianfu Li, et al.Expert Review of Vaccines|December 15, 2023
Plasmodium falciparum merozoite surface protein 1 as asexual blood stage malaria vaccine candidateRichard Thomson-Luque, Thomas C Stabler, Kristin Fürle, et al.Expert Review of Vaccines|December 14, 2023
Modelling the population-level benefits and cost-effectiveness of cell-based quadrivalent influenza vaccine for children and adolescents aged 6 months to 17 years in the USStephen I Pelton, Joaquin F Mould-Quevedo, Van Hung NguyenExpert Review of Vaccines|December 4, 2023
Modelling the Potential Public Health Impact of Different COVID-19 Vaccination Strategies with an Adapted Vaccine in SingaporeKaran Thakkar, Julia Spinardi, Moe H Kyaw, et al.Pageof 249